Literature DB >> 25794588

[Treatment of bladder cancer in the elderly].

M Fröhner1, H Rübben.   

Abstract

BACKGROUND: In Germany, bladder cancer is the fourth most common malignancy in males, while it occupies the 14th place in females. About 75% of cases occur in patients aged 65 or more years.
OBJECTIVES: Elderly patients with nonmuscle-invasive bladder cancer appear to harbor a higher risk of disease recurrence and progression and should undergo the same treatment and careful surveillance as their younger counterparts. Elderly patients with muscle-invasive bladder cancer undergoing radical cystectomy are at an increased risk of perioperative morbidity and mortality and should be referred to experienced high-volume centers.
CONCLUSION: Beside radical cystectomy as standard treatment, several bladder-sparing approaches (transurethral resection, chemotherapy, radiotherapy, chemoradiotherapy) are available which may be treatment alternatives in carefully selected cases. Valid randomized comparisons between these approaches and radical cystectomy are, however, still lacking.

Entities:  

Mesh:

Year:  2015        PMID: 25794588     DOI: 10.1007/s00120-015-3777-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  23 in total

1.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.

Authors:  Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew
Journal:  J Clin Oncol       Date:  2011-08-01       Impact factor: 44.544

2.  Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.

Authors:  Atiqullah Aziz; Matthias May; Maximilian Burger; Rein-Jüri Palisaar; Quoc-Dien Trinh; Hans-Martin Fritsche; Michael Rink; Felix Chun; Thomas Martini; Christian Bolenz; Roman Mayr; Armin Pycha; Philipp Nuhn; Christian Stief; Vladimir Novotny; Manfred Wirth; Christian Seitz; Joachim Noldus; Christian Gilfrich; Shahrokh F Shariat; Sabine Brookman-May; Patrick J Bastian; Stefan Denzinger; Michael Gierth; Florian Roghmann
Journal:  Eur Urol       Date:  2013-12-27       Impact factor: 20.096

3.  Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.

Authors:  Nicholas D James; Syed A Hussain; Emma Hall; Peter Jenkins; Jean Tremlett; Christine Rawlings; Malcolm Crundwell; Bruce Sizer; Thiagarajan Sreenivasan; Carey Hendron; Rebecca Lewis; Rachel Waters; Robert A Huddart
Journal:  N Engl J Med       Date:  2012-04-19       Impact factor: 91.245

4.  Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer.

Authors:  Matthew D Galsky; Susan Krege; Chia-Chi Lin; Noah Hahn; Thorsten H Ecke; Erin Moshier; Guru Sonpavde; James Godbold; William K Oh; Aristotle Bamias
Journal:  Urol Oncol       Date:  2013-02-18       Impact factor: 3.498

5.  Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.

Authors:  John J Coen; Jonathan J Paly; Andrzej Niemierko; Donald S Kaufman; Niall M Heney; Daphne Y Spiegel; Jason A Efstathiou; Anthony L Zietman; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-03-06       Impact factor: 7.038

6.  Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer.

Authors:  Catharina A Goossens-Laan; Anna M Leliveld; Rob H A Verhoeven; Paul J M Kil; Geertruida H de Bock; Maarten C C M Hulshof; Igle J de Jong; Jan Willem W Coebergh
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

7.  Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

Authors:  Jesus Fernandez-Gomez; Rosario Madero; Eduardo Solsona; Miguel Unda; Luis Martinez-Piñeiro; Marcelino Gonzalez; Jose Portillo; Antonio Ojea; Carlos Pertusa; Jesus Rodriguez-Molina; Jose Emilio Camacho; Mariano Rabadan; Ander Astobieta; Manuel Montesinos; Santiago Isorna; Pedro Muntañola; Anabel Gimeno; Miguel Blas; Jose Antonio Martinez-Piñeiro
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

8.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

9.  The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.

Authors:  Jorg R Oddens; Richard J Sylvester; Maurizio A Brausi; Wim J Kirkels; Cees van de Beek; George van Andel; Theo M de Reijke; Stephen Prescott; J Alfred Witjes; Willem Oosterlinck
Journal:  Eur Urol       Date:  2014-06-16       Impact factor: 20.096

10.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.